Trial Profile
An Escalating Single Intradermal or Subcutaneous Dose Study in Cat Allergic Subjects to Assess the Safety of Cat Allergy Immunotherapy [Cat-PAD]
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 31 Aug 2023
Price :
$35
*